Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
TSHA.OQ - Taysha Gene Therapies Inc
Taysha Gene Therapies Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual)
Apr 01, 2022 / 08:00PM GMT
=====================
Conference Call Participants
=====================
* Debjit Chattopadhyay
Guggenheim Securities - Senior Biotech Analyst
* Suyash Prasad
Taysha Gene Therapies Inc. - Chief Medical Officer
* Kamran Alam
Taysha Gene Therapies Inc. - CFO
=====================
Presentation
--------------------------------------------------------------------------------
Debjit Chattopadhyay, Guggenheim Securities - Senior Biotech Analyst [1]
--------------------------------------------------------------------------------
Good afternoon and thank you for joining Guggenheim's genomic medicines and rare disease conference day 2 and the last fireside chat of the event. I am Debjit, and one of the analysts representing Guggenheim Therapeutics team. Our privilege to host Taysha's Chief Medical Officer and head of R&D Suyash
